Extended Treatment Access Study of MT-3724 for Subjects With Relapsed Non-Hodgkin's B-Cell Lymphoma
NCT02715843
·
clinicaltrials.gov ↗
NO_LONGER_AVAILABLE
Status
INDUSTRY
Sponsor class
Conditions
Non-Hodgkin's B-cell Lymphoma
Interventions
DRUG:
MT-3724
Sponsor
Molecular Templates, Inc.